A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly from tumor biopsy slides has been developed by a team led by engineers and medical researchers at University of California San Diego.
Beyond Addiction: Stanford Explores Ibogaine for Brain Injury
The TDR Three Takeaways: Promising Treatment for TBI: Stanford Medicine’s study shows that Ibogaine, when combined with magnesium, may offer significant improvements in symptoms related
January 9, 2024